LGND
NASDAQ · Pharmaceuticals
Ligand Pharmaceuticals
$293.15
-6.99 (-2.33%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+57.64%
1Y
+99.41%
YTD
+54.20%
Open$304.37
Previous Close$300.14
Day High$304.60
Day Low$286.65
52W High$326.63
52W Low$132.21
Volume—
Avg Volume303.3K
Market Cap5.98B
P/E Ratio38.95
EPS$7.42
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$193.47
Above
SMA 200
$162.08
Above
RSI (14)
38.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
-89.2% upside
Current
$293.15
$293.15
Target
$31.56
$31.56
$18.80
$31.56 avg
$35.41
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 269.56M | 242.91M | 944.72M |
| Net Income | 125.13M | 101.49M | 258.92M |
| Profit Margin | 46.4% | 44.1% | 27.4% |
| EBITDA | 74.11M | 63.45M | 346.84M |
| Free Cash Flow | — | — | 167.31M |
| Rev Growth | +11.0% | +11.0% | +8.5% |
| Debt/Equity | 0.44 | 0.44 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |